The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers
Abstract
Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Nanoparticles: Properties, applications and toxicities
Khan, I., Saeed, K., & Khan, I. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2017.05.011 · Cited by 6,244
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., & Bruchez, M. P. (2003) · Nature Biotechnology · doi:10.1038/nbt764 · Cited by 2,506
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
Hardman, R. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8284 · Cited by 2,303
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Drug delivery systems: An updated review
Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671
"Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies
BUHLEIER, E., WEHNER, W., & VÖGTLE, F. (1978) · Synthesis · doi:10.1055/s-1978-24702 · Cited by 1,285
In vivo molecular and cellular imaging with quantum dots
Gao, X., Yang, L., Petros, J. A., Marshall, F. F., Simons, J. W., & Nie, S. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.003 · Cited by 1,211
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,000
Nanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction
Lidke, D. S., Nagy, P., Heintzmann, R., Arndt-Jovin, D. J., Post, J. N., Grecco, H. E., Jares-Erijman, E. A., & Jovin, T. M. (2004) · Nature Biotechnology · doi:10.1038/nbt929 · Cited by 828
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer
Popovtzer, R., Agrawal, A., Kotov, N. A., Popovtzer, A., Balter, J., Carey, T. E., & Kopelman, R. (2008) · Nano Letters · doi:10.1021/nl8029114 · Cited by 801
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.130965 · Cited by 679
Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Nanopharmaceuticals (part 1): products on the market
Weissig, V., Pettinger, T., & Murdock, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s46900 · Cited by 591
Polymeric Conjugates for Drug Delivery
Larson, N., & Ghandehari, H. (2012) · Chemistry of Materials · doi:10.1021/cm2031569 · Cited by 580
Nonadditivity of nanoparticle interactions
Silvera Batista, C. A., Larson, R. G., & Kotov, N. A. (2015) · Science · doi:10.1126/science.1242477 · Cited by 559
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B., & Brindle, K. M. (2001) · Nature Medicine · doi:10.1038/nm1101-1241 · Cited by 521
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., et al. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0116-7 · Cited by 513
Park, J. Y., Baek, M. J., Choi, E. S., Woo, S., Kim, J. H., Kim, T. J., Jung, J. C., Chae, K. S., Chang, Y., & Lee, G. H. (2009) · ACS Nano · doi:10.1021/nn900761s · Cited by 504
Hydrogels for Therapeutic Delivery: Current Developments and Future Directions
Buwalda, S. J., Vermonden, T., & Hennink, W. E. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01604 · Cited by 497
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
Reddy, G. R., Bhojani, M. S., McConville, P., Moody, J., Moffat, B. A., Hall, D. E., Kim, G., Koo, Y.-E. L., Woolliscroft, M. J., Sugai, J. V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0946 · Cited by 491
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Li, S.-D., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 486
Spectroscopic Tags Using Dye-Embedded Nanoparticles and Surface-Enhanced Raman Scattering
Doering, W. E., & Nie, S. (2003) · Analytical Chemistry · doi:10.1021/ac034672u · Cited by 470
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Polymeric Nanoparticles, Nanospheres and Nanocapsules, for Cutaneous Applications
Guterres, S. S., Alves, M. P., & Pohlmann, A. R. (2007) · Drug Target Insights · doi:10.1177/117739280700200002 · Cited by 461
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
Jordan, A., Scholz, R., Maier-Hauff, K., van Landeghem, F. K. H., Waldoefner, N., Teichgraeber, U., Pinkernelle, J., Bruhn, H., Neumann, F., Thiesen, B., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9059-z · Cited by 459
Laurent, S., Saei, A. A., Behzadi, S., Panahifar, A., & Mahmoudi, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.924501 · Cited by 445
Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona
Caracciolo, G., Farokhzad, O. C., & Mahmoudi, M. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.011 · Cited by 426
Chauhan, A. S. (2018) · Molecules · doi:10.3390/molecules23040938 · Cited by 425
Hadjipanayis, C. G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A. J., Chen, H., Wu, X., & Mao, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1022 · Cited by 419
Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots
Giepmans, B. N. G., Deerinck, T. J., Smarr, B. L., Jones, Y. Z., & Ellisman, M. H. (2005) · Nature Methods · doi:10.1038/nmeth791 · Cited by 388
Control of polymeric nanoparticle size to improve therapeutic delivery
Hickey, J. W., Santos, J. L., Williford, J.-M., & Mao, H.-Q. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.006 · Cited by 379
Polymeric micelles: nanocarriers for cancer-targeted drug delivery
Zhang, Y., Huang, Y., & Li, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0113-z · Cited by 367
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Ali, A., & Ahmed, S. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01052 · Cited by 304
Liposome: composition, characterisation, preparation, and recent innovation in clinical applications
Ahmed, K. S., Hussein, S. A., Ali, A. H., Korma, S. A., Lipeng, Q., & Jinghua, C. (2019) · Journal of Drug Targeting · doi:10.1080/1061186x.2018.1527337 · Cited by 294
Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry
Perez, O. D., & Nolan, G. P. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-155 · Cited by 279
Xiao, W., & Gao, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.011 · Cited by 256
Caracciolo, G. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.11.003 · Cited by 246
Rupp, R. E., Rosenthal, S. L., & Stanberry, L. R. (2007) · PubMed · Cited by 235
Moore, B. D., Stevenson, L., Watt, A., Flitsch, S., Turner, N. J., Cassidy, C., & Graham, D. (2004) · Nature Biotechnology · doi:10.1038/nbt1003 · Cited by 200
Nanoparticles with multiple properties for biomedical applications: A strategic guide
De Crozals, G., Bonnet, R., Farre, C., & Chaix, C. (2016) · Nano Today · doi:10.1016/j.nantod.2016.07.002 · Cited by 195
Self-Assembled Hydrogel Nanoparticles for Drug Delivery Applications
Gonçalves, C., Pereira, P., & Gama, M. (2010) · Materials · doi:10.3390/ma3021420 · Cited by 193
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.
Laurent, S., & Mahmoudi, M. (2011) · PubMed · Cited by 184
Optical Imaging and Magnetic Field Targeting of Magnetic Nanoparticles in Tumors
Foy, S. P., Manthe, R. L., Foy, S. T., Dimitrijevic, S., Krishnamurthy, N., & Labhasetwar, V. D. (2010) · ACS Nano · doi:10.1021/nn101427t · Cited by 162
Jung, J., Solanki, A., Memoli, K. A., Kamei, K., Kim, H., Drahl, M. A., Williams, L. J., Tseng, H., & Lee, K. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200905126 · Cited by 157
Lipids and polymers in pharmaceutical technology: Lifelong companions
Siepmann, J., Faham, A., Clas, S., Boyd, B. J., Jannin, V., Bernkop‐Schnürch, A., Zhao, H., Lecommandoux, S., Evans, J. C., Allen, C. J., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.080 · Cited by 156
Tumor Ablation and Nanotechnology
Manthe, R. L., Foy, S. P., Krishnamurthy, N., Sharma, B., & Labhasetwar, V. D. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001944 · Cited by 136
Faulds, K., Smith, W. E., Graham, D., & Lacey, R. J. (2002) · The Analyst · doi:10.1039/b107318b · Cited by 136
Nanoparticles for Imaging and Treating Brain Cancer
Meyers, J. D., Doane, T. L., Burda, C., & Basilion, J. P. (2012) · Nanomedicine · doi:10.2217/nnm.12.185 · Cited by 135
Targeted Delivery of Nanomedicines
Khanna, V. K. (2012) · ISRN Pharmacology · doi:10.5402/2012/571394 · Cited by 123
Remsen, L. G., McCormick, C. I., Roman-Goldstein, S., Nilaver, G., Weissleder, R., Bogdanov, A. A., Jr., Hellström, K. E., Kroll, R. A., & Neuwelt, E. A. (1996) · PubMed Central · Cited by 123
Vesicles-on-a-chip: A universal microfluidic platform for the assembly of liposomes and polymersomes
Petit, J., Polenz, I., Baret, J., Herminghaus, S., & Bäumchen, O. (2016) · The European Physical Journal E · doi:10.1140/epje/i2016-16059-8 · Cited by 116
Ultra‐small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI
Faucher, L., Guay‐Bégin, A., Lagueux, J., Côté, M., Petitclerc, É., & Fortin, M. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.420 · Cited by 114
Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
Costantino, L., & Boraschi, D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.028 · Cited by 114
Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics
McNeil, S. E. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_1 · Cited by 109
Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona
Caracciolo, G. (2018) · Nanoscale · doi:10.1039/c7nr07450f · Cited by 106
Delivery of Nanoparticles for Treatment of Brain Tumor
Chen, K., Sun, Y., Zhu, J., Li, W., Zhang, A., Kuang, T., Xie, J., & Yang, Z. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160728152939 · Cited by 103
The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy
Karra, N., & Benita, S. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356899 · Cited by 102
Orringer, D. A., Koo, Y., Chen, T., Kopelman, R., Sagher, O., & Philbert, M. A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.296 · Cited by 99
Poloxamine-based nanomaterials for drug delivery
Alvarez‐Lorenzo, C. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e102 · Cited by 99
Actively Targeted Nanoparticles for Drug Delivery to Tumor
Bi, Y., Hao, F., Yan, G., Teng, L., Lee, R. J., & Xie, J. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160619191853 · Cited by 93
Multifunctional imaging nanoprobes
Jarzyna, P. A., Gianella, A., Skajaa, T., Knudsen, G. M., Deddens, L. H., Cormode, D. P., Fayad, Z. A., & Mulder, W. J. M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.72 · Cited by 88
Hong, R., & Tseng, Y. (2001) · Cancer · doi:10.1002/1097-0142(20010501)91:9<1826::aid-cncr1203>3.0.co;2-j · Cited by 84
Caracciolo, G., Palchetti, S., Digiacomo, L., Chiozzi, R. Z., Capriotti, A. L., Amenitsch, H. W., Tentori, P. M., Palmieri, V., Papi, M., Cardarelli, F., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04962 · Cited by 73
Serrano‐García, R., Stafford, S., & Gun’ko, Y. K. (2018) · Applied Sciences · doi:10.3390/app8020172 · Cited by 71
Nanotechnology tools in pharmaceutical R&D
Kumar, C. S. S. R. (2010) · Materials Today · doi:10.1016/s1369-7021(10)70142-5 · Cited by 50
Fundueanu, G., Constantin, M., Stanciu, C., et al. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3807-0 · Cited by 49
Exploitation of nanoparticle–protein corona for emerging therapeutic and diagnostic applications
Palchetti, S., Pozzi, D., Mahmoudi, M., & Caracciolo, G. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01095d · Cited by 36
The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies
Singh, V. K., Saini, A., & Chandra, R. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00052 · Cited by 31
Mariyam, M., Ghosal, K., Thomas, S., Kalarikkal, N., & Latha, M. S. (2017) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557517666170512095151 · Cited by 30
Asymmetrical Polymer Vesicles for Drug delivery and Other Applications
Zhao, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00374 · Cited by 30
Javid, S., Ziamajidi, N., Foroughi, S., & Abbasalipourkabir, R. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.055 · Cited by 19
Cited by
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A., Ruokolainen, J., & Kesari, K. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07840 · Cited by 348
Wu, Y., Wan, S., Yang, S., Hu, H., Zhang, C., Lai, J., Zhou, J., Chen, W., Tang, X., Luo, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01746-6 · Cited by 301
Abedizadeh, R., Majidi, F., Khorasani, H. R., Abedi, H., & Sabour, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10158-3 · Cited by 293
Kirubakaran, D., Wahid, J. B. A., Karmegam, N., Jeevika, R., Sellapillai, L., Rajkumar, M., & SenthilKumar, K. J. (2026) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00295-4 · Cited by 281
Doped Zinc Oxide Nanoparticles: Synthesis, Characterization and Potential Use in Nanomedicine
Carofiglio, M., Barui, S., Cauda, V., & Laurenti, M. (2020) · Applied Sciences · doi:10.3390/app10155194 · Cited by 262
Metadata
- Authors
- Aghebati‐Maleki, A., Dolati, S., Ahmadi, M., Baghbanzhadeh, A., Asadi, M., Fotouhi, A., Yousefi, M., & Aghebati‐Maleki, L.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-08-22
- Volume
- 235
- Issue
- 3
- Pages
- 1962-1972
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2969376266
- Cited by
- 417
- References
- 89
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.